Bortezomib Enhances Antigen-Specific Cytotoxic T Cell Responses Against Immune-Resistant Cancer Cells Generated by STAT3-ablated Dendritic Cells
Pharmacological Research - United States
doi 10.1016/j.phrs.2013.02.001
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2013
Authors
Publisher
Elsevier BV